The Vanguard Group 13D and 13G filings for Vertex Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:17 pm Purchase |
2023-12-29 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
The Vanguard Group | 22,281,729 8.650% |
734,826 (+3.41%) |
Filing |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
The Vanguard Group | 21,546,903 8.390% |
1,391,061 (+6.90%) |
Filing |
| 2022-02-10 08:42 am Sale |
2021-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
The Vanguard Group | 20,155,842 7.930% |
-277,208 (-1.36%) |
Filing |
| 2021-02-10 12:00 pm Purchase |
2020-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
The Vanguard Group | 20,433,050 7.860% |
338,816 (+1.69%) |
Filing |